These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2409932)

  • 1. Antibodies to orthokeratotic keratinocytes in monitoring the drug-induced inhibition of parakeratotic differentiation in adult and infant mice.
    Wrench R; Didierjean L
    Arch Dermatol Res; 1985; 277(3):201-8. PubMed ID: 2409932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytoplasmic antigens linked to orthokeratosis during the development of parakeratosis in newborn mouse tail epidermis.
    Didierjean L; Wrench R; Saurat JH
    Differentiation; 1983; 23(3):250-5. PubMed ID: 6189756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect on epidermal DNA synthesis of a combination of topical steroid with either dithranol or tar as used for psoriasis.
    Clement M; Hehir M; Phillips H; du Vivier A
    Br J Dermatol; 1983 Sep; 109(3):327-35. PubMed ID: 6615719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of coal tar fractions for use in psoriasiform diseases using the mouse tail test. III. High boiling tar oil acids.
    Wrench R; Britten AZ
    Br J Dermatol; 1975 Jul; 93(1):67-74. PubMed ID: 1191530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoquinoline is a possible anti-psoriatic agent in coal tar.
    Foreman MI; Taylor M; Clark C; Devitt H; Hanlon G; Kelly I; Lukowiecki G
    Br J Dermatol; 1985 Mar; 112(3):323-8. PubMed ID: 2579670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of coal tar fractions for use in psoriasiform diseases using the mouse tail test. (II) Tar oil acids.
    Wrench R; Britten AZ
    Br J Dermatol; 1975 May; 92(5):575-9. PubMed ID: 1174470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructure of murine epidermis treated with the vitamin D3 analogue KH-1060.
    Kobayasi T; Gniadecki R; Serup J
    Acta Derm Venereol; 1995 May; 75(3):222-7. PubMed ID: 7544521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of keratin and associated proteins in the epidermis of monotreme, marsupial, and placental mammals.
    Alibardi L; Maderson PF
    J Morphol; 2003 Oct; 258(1):49-66. PubMed ID: 12905534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 2. Anti-inflammatory and anti-lymphocyte activities.
    Young JM; Wagner BM; Fisk RA
    Br J Dermatol; 1978 Dec; 99(6):665-73. PubMed ID: 737129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of coal tar fractions for use in psoriasiform diseases using the mouse tail test. (I) High and low temperature tars and their constituents.
    Wrench R; Britten AZ
    Br J Dermatol; 1975 May; 92(5):569-74. PubMed ID: 1174469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of betamethasone 17 valerate on the cyclic AMP system of the pig skin epidermis.
    Ishizawa H; Iizuka H; Kajita S; Ohkawara A
    J Dermatol; 1983 Aug; 10(4):321-5. PubMed ID: 6321577
    [No Abstract]   [Full Text] [Related]  

  • 12. A quantitative method for measuring antipsoriatic activity of drugs by the mouse tail test.
    Bosman B; Matthiesen T; Hess V; Friderichs E
    Skin Pharmacol; 1992; 5(1):41-8. PubMed ID: 1575981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid effect on epidermal cell size.
    Delforno C; Holt PJ; Marks R
    Br J Dermatol; 1978 Jun; 98(6):619-23. PubMed ID: 678451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evaluation of a new topical preparation containing dextran sulphate and betamethasone 17-valerate.
    Passarella E; Milanino R
    Arzneimittelforschung; 1980; 30(4):647-51. PubMed ID: 6156688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid atrophy--a histological appraisal.
    Jones EW
    Dermatologica; 1976; 152 Suppl 1():107-15. PubMed ID: 133833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of crude coal tar in the mouse-tail model of psoriasis.
    Bladon PT; Taylor M; Wood EJ; Cunliffe WJ
    Arch Dermatol Res; 1985; 277(2):121-5. PubMed ID: 2580494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stability and blanching efficacy of betamethasone-17-valerate in emulsifying ointment.
    Ryatt KS; Feather JW; Mehta A; Dawson JB; Cotterill JA; Swallow R
    Br J Dermatol; 1982 Jul; 107(1):71-6. PubMed ID: 7104209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of acid mucopolysaccharide synthesis by hydrocortisone, hydrocortisone 17-butyrate and betamethasone 17-valerate.
    Saarni H; Hopsu-Havu VK
    Br J Dermatol; 1977 Nov; 97(5):505-7. PubMed ID: 145236
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study of tar and betamethasone valerate in chronic plaque psoriasis: a study in Thailand.
    Thawornchaisit P; Harncharoen K
    J Med Assoc Thai; 2007 Oct; 90(10):1997-2002. PubMed ID: 18041415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 1. Dermal atrophy.
    Young JM; Yoxall BE; Wagner BM
    Br J Dermatol; 1978 Dec; 99(6):655-63. PubMed ID: 737128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.